Treatment of Lobular Carcinoma in Situ in Israel

Breast cancer is a disease that affects an increasing number of women each year. In the classification of this pathology, non-invasive forms of cancer, known as precancers, are distinguished: ductal and lobular carcinoma in situ. Lobular (lobular) carcinoma in situ is rare, making its diagnosis and treatment very challenging. However, in Israel, even the rarest diseases are treated with high professionalism: Israeli doctors master the treatment methods for all known pathologies. At the Top Ihilov Medical Center, the treatment of lobular carcinoma poses no difficulties, as the doctors working in this clinic are the best specialists in the country. Patients with lobular carcinoma in situ who turn to the Top Ihilov clinic will not regret their choice for a second.

What is lobular carcinoma in situ?

Lobular carcinoma in situ manifests as uncontrolled development of atypical cells in the lobules of the mammary glands. In most cases, cancer cells are spread throughout the thickness of the breast, and lobular carcinoma often develops simultaneously in both breasts. Some doctors claim that lobular non-invasive cancer is not life-threatening for women and that no specific treatment is required for patients with such a diagnosis.

Israeli specialists deny the correctness of this statement, as it is enough to familiarize oneself with statistical data to understand that treatment of lobular carcinoma in situ significantly reduces the risk of developing invasive breast cancer in the future. At the Top Ihilov clinic, patients diagnosed with "lobular carcinoma in situ" receive comprehensive treatment aimed at the maximum removal of tumour tissue.

Lobular carcinoma in situ: causes and symptoms of the disease

The causes of lobular carcinoma development are not well understood; however, doctors have identified risk factors for this disease:

• Hereditary predisposition;
• Early menstruation;
• Late first childbirth or complete absence of childbirth;
• Age of the woman (40-45 years);
• Prolonged hormone therapy.
• Exposure to ionizing radiation, including undergoing radiation therapy.

Lobular carcinoma is practically impossible to recognize, as it does not manifest itself: patients with this disease have no mammological signs (such as breast lumps, nipple discharge, etc.).

Breast cancer - treatment in Israel

Lobular carcinoma in situ: treatment in Israel

There are several treatment methods for lobular carcinoma in situ, all of which differ radically from each other in terms of the extent of intervention and effectiveness.

1. Excisional biopsy with subsequent monitoring. This type of biopsy involves the removal of the detected tumour along with a portion of the surrounding tissues. This intervention is performed under local anesthesia. If the patient prefers this type of treatment, she will need to undergo annual check-ups with a specialist and, if necessary, repeat biopsies. Mammography, CT, and/or MRI must be performed at least once a year.
2. Hormonal therapy. Since lobular carcinoma in situ is an estrogen-dependent tumour, hormone therapy is quite effective and reduces the risk of the patient developing invasive cancer. Hormonal medications are prescribed in conjunction with excisional biopsy.
3. Bilateral prophylactic total mastectomy. Complete removal of the breasts to prevent the development of invasive cancer. Many surgeons consider such a radical operation unnecessary; however, if the patient is at risk and agrees to undergo surgery, Israeli surgeons will perform the mastectomy at the highest level. Top Ihilov also employs highly skilled plastic surgeons who can immediately begin breast reconstruction.

Diagnosis of lobular carcinoma in situ in Israel

Detecting lobular carcinoma in situ is extremely difficult; the tumour can only be diagnosed during examination at a clinic equipped with the latest technology. Mammography, one of the most common methods for examining the breast, is ineffective for this pathology, and physical examination is also inadequate. At the Top Ihilov Medical Center, a diagnostic program has been developed and implemented that allows for the detection of lobular carcinoma and its differentiation from other types of tumours. A patient suspected of having lobular carcinoma in situ undergoes the following procedures:

• Mammography (to rule out other oncological diseases of the breast);
• CT;
• MRI;
• Biopsy with subsequent cytological examination;
• Blood test for tumor markers;
• Estrogen receptor testing (lobular carcinoma in situ is hormone-dependent).